Additional funding opportunities
Research Funding Opportunities
Grants Awarded for Health Sciences Research
| Title | Type | $ Amount | Activity | Investigator | Unit | Sponsor |
Date |
|---|---|---|---|---|---|---|---|
| A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. | Contract | $327,830.00 | Clinical Trial | Abhijeet Kumar | Cancer Center Division | Covance, Incorporated | 01/2020 |
| Phase 3b Study for Evaluation of Efficacy and Nutritional Benefits of Pancrelipase in Patients with Exocrine Pancreatic Insufficiency due to Periampullary and Pancreatic Cancer | Contract | $122,409.40 | Clinical Trial | Hani Babiker | Cancer Center Division | AbbVie Incorporated | 01/2020 |
| The MITRAL Trial (Mitral Implantation of TRAnscatheter VaLves is Native Mitral Stenosis) | Contract | $62,000.00 | Clinical Trial | Ashish Pershad | COM Phx Internal Medicine | Mayo Foundation for Medical Education and Research (Mayo Clinic) | 01/2020 |
| Inflammatory Bowel/Disease West | Contract | $10,000.00 | Instruction | Sasha Taleban | Medicine | Celgene Corporation | 01/2020 |
| TransitionInAction Clinic | Contract | $49,297.00 | Other Sponsored Activity | Wendy Parent-Johnson | Family and Community Medicine | Arizona Developmental Disabilities Planning Council | 01/2020 |
| Evaluation of Drug Efficacy in a Rat Model of Neuropathic Pain | Contract | $275,676.00 | Research | Rajesh Khanna | Pharmacology | Lovelace Biomedical and Environmental Research Institute | 01/2020 |
| Exploring the Neurobiology of the Premonitory Phase of Migraine Preclinically | Contract | $149,875.50 | Research | Caroline Kopruszinski | Pharmacology | Amgen | 01/2020 |
| Firefighter Cancer Cohort Study - PFAS Testing | Contract | $2,600.00 | Research | Jefferey Burgess | Community Environment & Policy | Tucson Airport Authority Fire Department | 01/2020 |
| Infertility History and Chronic Disease Profile | Grant | $242,040.00 | Research | Leslie Farland | Epidemiology and Biostatistics | Michigan State University | 01/2020 |
| Salary support for Amani Morgan Mikail | Contract | $119,988.00 | Other Sponsored Activity | Madhan Shanmugasundaram | Sarver Heart Center | Biomedical Research and Education Foundation of Southern Arizona | 01/2020 |
| Prescribing Vitamin D: An Exploratory Comparative Survey of University of Arizona Integrative Medicine Fellows' Attitudes and Practices | Contract | $101,919.00 | Research | Lisa Alschuler | Andrew Weil Ctr Intgrtv Med | Pharmavite | 01/2020 |
| A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer | Contract | $91,617.50 | Clinical Trial | Pavani Chalasani | Cancer Center Division | Zeno Pharmaceuticals, Inc. | 01/2020 |
| Traumatic Brain Injury, Alzheimer's Disease, Probiotics, and Cognitive Function | Contract | $50,000.00 | Research | Jonathan Lifshitz | COM Phx Child Health | Arizona Alzheimer's Consortium | 01/2020 |
| A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors | Contract | $458,027.74 | Clinical Trial | Hani Babiker | Cancer Center Division | Parexel International Corporation | 01/2020 |
| Validity and Usefulness of an Exposure Score and Profile for Chronic Pain Management | Grant | $10,000.00 | Research | David Axon | Pharmacy Practice and Science | American Association of Colleges of Pharmacy | 01/2020 |
| A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses.... | Contract | $273,767.50 | Clinical Trial | Cori Daines | Asthma/Airway Disease Rsch Ctr | Janssen Research & Development, LLC | 01/2020 |
| MIS General Surgery Fellowship Grant (2020-2021) | Fellowship | $20,000.00 | Research Training | Iman Ghaderi | Surgery | Foundation for Surgical Fellowships | 01/2020 |
| A Phase 2, Multi-Center, Open-Label Study to Evaluate Long-term Safety and Efficacy of CXA-10 in Subjects with Pulmonary Arterial Hypertension on Stable Background Therapy: Extension to Study CXA-10-3 | Contract | $80,418.76 | Clinical Trial | Franz Rischard | Medicine | Complexa, Inc. | 01/2020 |
| Patient-Specific iPSCs-Derived Vascularized Organoids for Investigating Differential Susceptibility to E-cigarette | Fellowship | $135,352.00 | Research Training | Chen-wei Liu | COM Phx Basic Medical Sci | American Heart Association, Incorporated | 01/2020 |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Efficacy and Safety of Anamorelin HCL for the Treatment OF Malignancy Associated Weight Loss and Anorexia... | Contract | $42,626.00 | Clinical Trial | Charles Hsu | Cancer Center Division | PSI Pharma Support America, Incorporated | 01/2020 |
| Using Endothelial Cell Molecular Quantitative Trait Loci to Dissect Coronary Artery Disease Risk | Grant | $62,032.00 | Research Training | Lindsey Stolze | Cellular & Molecular Medicine | American Heart Association, Incorporated | 01/2020 |
| A Phase Ib/II Study of APG-115 in Combination with Pembrolizumab in Patients with Unresectable or Metastatic Melanomas or Advanced Solid Tumors | Contract | $513,891.00 | Clinical Trial | Montaser Shaheen | Cancer Center Division | Ascentage Pharma | 01/2020 |
| Chemotherapy Induced Peripheral Neuropathy Natural History Study (EPIPHANY) | Contract | $159,936.00 | Clinical Trial | Pavani Chalasani | Cancer Center Division | IQVIA RDS Inc. | 02/2020 |
| The Role of Hedgehog Signaling in Gastric Tissue Repair and Regeneration | Grant | $301,342.00 | Research | Yana Zavros | Cellular & Molecular Medicine | National Institute of Diabetes and Digestive and Kidney Diseases | 02/2020 |
| Elecestrant Monotherapy VS. Standard Of Care For The Treatment Of Patients With ER+/HER2- Advanced Breast Cancer Following CDK4/6 Inhibitor Therapy: A Phase 3 Randomized, OPEN-LABEL, Active-Controlled | Contract | $369,650.07 | Clinical Trial | Pavani Chalasani | Cancer Center Division | Radius Health, Inc. | 02/2020 |